E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma by Mina Maksimos, Barbara Muz, John L. Magnani, Abdel Kareem Azab

Get full text

Targeting Neutrophil Adhesive Events to Address Vaso-Occlusive Crisis in Sickle Cell Patients by Vasilios A. Morikis, Alfredo A. Hernandez, John L. Magnani, Markus Sperandio, Scott I. Simon

Get full text

Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia. by Ted Wun, Lori Styles, Laura DeCastro, Marilyn J Telen, Frans Kuypers, Anthony Cheung, William Kramer, Henry Flanner, Seungshin Rhee, John L Magnani, Helen Thackray

Get full text

Design and Synthesis of E-Selectin Antagonists by Beat Ernst, Thomas Peters, Reinhold Oehrlein, Keith E. Norman, John L. Magnani, Wolfgang Jahnke, Beatrice Wagner, Christian Müller, Sébastien Marti, Zorica Dragic, Hartmuth C. Kolb

Get full text

Use of GMI‐1271, an E‐selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis by Sumana Devata, Dana E. Angelini, Susan Blackburn, Angela Hawley, Daniel D. Myers, Jordan K. Schaefer, Martina Hemmer, John L. Magnani, Helen M. Thackray, Thomas W. Wakefield, Suman L. Sood

Get full text

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance by Valerie Barbier, Johanna Erbani, Corrine Fiveash, Julie M. Davies, Joshua Tay, Michael R. Tallack, Jessica Lowe, John L. Magnani, Diwakar R. Pattabiraman, Andrew C. Perkins, Jessica Lisle, John E. J. Rasko, Jean-Pierre Levesque, Ingrid G. Winkler

Get full text